UniProt | Protein Name |
---|---|
P51857 |
|
GO Term | Evidence Code | PMID |
---|---|---|
bile acid catabolic process | ||
bile acid biosynthetic process | ||
cholesterol catabolic process | ||
digestion | ||
androgen metabolic process |
GO Term | Evidence Code | PMID |
---|---|---|
delta4-3-oxosteroid 5beta-reductase activity | ||
alditol:NADP+ 1-oxidoreductase activity | ||
steroid binding |
|
|
aldo-keto reductase (NADP) activity |
|
|
ketosteroid monooxygenase activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:0014667 | disease of metabolism | |
DOID:0050674 | congenital bile acid synthesis defect | |
DOID:0060262 | gallbladder disease | |
DOID:0111029 | hemochromatosis type 1 | |
DOID:0111069 | congenital bile acid synthesis defect 2 | |
DOID:10607 | tropical sprue | |
DOID:11476 | osteoporosis | |
DOID:11847 | coronary thrombosis | |
DOID:1247 | blood coagulation disease | |
DOID:12549 | hepatitis A |
HPO ID | HPO Term |
---|---|
HP:0002014 | Diarrhea |
HP:0002240 | Hepatomegaly |
HP:0002570 | Steatorrhea |
HP:0002630 | Fat malabsorption |
HP:0002748 | Rickets |
HP:0002904 | Hyperbilirubinemia |
HP:0002908 | Conjugated hyperbilirubinemia |
HP:0002910 | Elevated circulating hepatic transaminase concentration |
HP:0003155 | Elevated circulating alkaline phosphatase concentration |
HP:0003256 | Abnormality of the coagulation cascade |
Disease ID | Disease Name |
---|---|
ORPHA:79303 |
|
OMIM:235555 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
114605306 | PODMU33959 | ||
111573167 | AMPOC04444 | ||
106829989 | EQUAS13299 | ||
109529813 | HIPCM11285 | ||
105291623 | PTEVA06756 | ||
115036671 | ECHNA42701 | ||
115391701 | SALFA28788 | ||
103380315 | CYNSE25787 | ||
103382893 | CYNSE29038 | ||
103382913 | CYNSE29038 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024